Therefore, the present review aims to investigate the potential mechanisms and consolidate the existing clinical evidence regarding the emerging role of GLP-1 RAs in individuals with obesity-related HFpEF. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.